Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hanauer

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Digestive Diseases and Sciences|May 1, 1995
Quality-of-life results of double-blind, placebo-controlled trial of mesalamine in patients with Crohn's diseaseJ W Singleton, S Hanauer, M Robinson
Inflammatory Bowel Diseases|January 4, 2013
Length and type of recurrent ileitis after ileal resection correlate with presurgical features in Crohn's diseaseG Dʼhaens, F Baert, A Gasparaitis, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|October 14, 2006
Crohn's disease arthritis treated with infliximab: an open trial in four patientsM H Ellman, S Hanauer, M Sitrin, et al.
Alimentary Pharmacology & Therapeutics|February 16, 2005
Budesonide as maintenance treatment in Crohn's disease: a placebo-controlled trialS Hanauer, W J Sandborn, A Persson, et al.
Alimentary Pharmacology & Therapeutics|February 1, 1994
Mesalamine capsules enhance the quality of life for patients with ulcerative colitisM Robinson, S Hanauer, R Hoop, et al.
Digestive Diseases and Sciences|February 1, 1995
Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study GroupP Miner, S Hanauer, M Robinson, et al.
International Journal of Cancer|May 15, 1989
Tumor-associated glycoprotein (TAG-72) expression in ulcerative colitisA Thor, S H Itzkowitz, J Schlom, et al.
The American Journal of Gastroenterology|August 1, 1993
Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study GroupS Hanauer, J Schwartz, M Robinson, et al.
Alimentary Pharmacology & Therapeutics|August 19, 2011
Early symptomatic response and mucosal healing with mesalazine rectal suspension therapy in active distal ulcerative colitis--additional results from two controlled studiesW J Sandborn, S Hanauer, G R Lichtenstein, et al.
Bone Marrow Transplantation|July 1, 1995
Acute myeloid leukemia and myelodysplasia following intensive chemotherapy for breast cancerS Roman-Unfer, J D Bitran, S Hanauer, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Digestive Diseases and Sciences|May 1, 1995
Quality-of-life results of double-blind, placebo-controlled trial of mesalamine in patients with Crohn's diseaseJ W Singleton, S Hanauer, M Robinson
Inflammatory Bowel Diseases|January 4, 2013
Length and type of recurrent ileitis after ileal resection correlate with presurgical features in Crohn's diseaseG Dʼhaens, F Baert, A Gasparaitis, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|October 14, 2006
Crohn's disease arthritis treated with infliximab: an open trial in four patientsM H Ellman, S Hanauer, M Sitrin, et al.
Alimentary Pharmacology & Therapeutics|February 16, 2005
Budesonide as maintenance treatment in Crohn's disease: a placebo-controlled trialS Hanauer, W J Sandborn, A Persson, et al.
Alimentary Pharmacology & Therapeutics|February 1, 1994
Mesalamine capsules enhance the quality of life for patients with ulcerative colitisM Robinson, S Hanauer, R Hoop, et al.
Digestive Diseases and Sciences|February 1, 1995
Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study GroupP Miner, S Hanauer, M Robinson, et al.
International Journal of Cancer|May 15, 1989
Tumor-associated glycoprotein (TAG-72) expression in ulcerative colitisA Thor, S H Itzkowitz, J Schlom, et al.
The American Journal of Gastroenterology|August 1, 1993
Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study GroupS Hanauer, J Schwartz, M Robinson, et al.
Alimentary Pharmacology & Therapeutics|August 19, 2011
Early symptomatic response and mucosal healing with mesalazine rectal suspension therapy in active distal ulcerative colitis--additional results from two controlled studiesW J Sandborn, S Hanauer, G R Lichtenstein, et al.
Bone Marrow Transplantation|July 1, 1995
Acute myeloid leukemia and myelodysplasia following intensive chemotherapy for breast cancerS Roman-Unfer, J D Bitran, S Hanauer, et al.
Pageof 2